EyeGate Pharma’s broad iontophoresis patent portfolio for corneal collagen cross-linking will be held as exclusive license by Avedro Inc. Delivery approach provides potential additional benefits to current formulation.
Welcome to ModernMedicine
Mitomycin C following wavefront-guided PRK for high myopia had no dose-dependent effect on haze scores throughout the study.
Prevent Blindness America offers free educational materials to help the public, educators, and health professionals address diabetes and its visual consequences.
In a pilot phase II study, an intracanalicular plug (OTX-TP2, Ocular Therapeutics) shows promise for lowering IOP and increasing compliance with the treatment regimen.
Nicox S.A. announced the U.S. launch of a point-of-care diagnostic test (AdenoPlus) that aids in the differential diagnosis of acute conjunctivitis.
SARcode Bioscience Inc. announced the topline results from OPUS-1, a pivotal phase III study of lifitegrast ophthalmic solution 5.0% for the treatment of dry eye disease.
The Glaucoma Foundation has announced George L. Spaeth, MD, as the 2012 recipient of the foundation’s Dr. Robert Ritch Award for Innovation and Excellence in Glaucoma.
Current multifocal IOLs have some limitations that in specific situations are overcome with the dual-optic accommodating IOL (Synchrony, Abbott Medical Optics).
A new strategy that uses the femtosecond laser to make a side cut for postLASIK re-treatment may reduce the incidence of epithelial ingrowth.
Antibiotic injections following cataract surgery were found to reduce risk of postop endophthalmitis by 22-fold.